Henry Krum Selected Research

tezosentan

1/2017	Measurement of troponin and natriuretic peptides shortly after admission in patients with heart failure-does it add useful prognostic information? An analysis of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Studies (VERITAS).
11/2007	Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.
7/2005	Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).
3/2003	Current status of endothelin blockade for the treatment of cardiovascular and pulmonary vascular disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henry Krum Research Topics

Disease

179	Heart Failure 10/2021 - 05/2002
66	Hypertension (High Blood Pressure) 01/2018 - 03/2002
41	Myocardial Infarction 01/2020 - 01/2002
35	Fibrosis (Cirrhosis) 01/2020 - 08/2003
24	Systolic Heart Failure 01/2016 - 07/2006
23	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 01/2002
19	Hypertrophy 10/2021 - 08/2003
17	Chronic Renal Insufficiency 01/2018 - 02/2007
14	Left Ventricular Dysfunction 01/2020 - 08/2002
12	Cardio-Renal Syndrome 01/2021 - 06/2009
9	Atrial Fibrillation 01/2022 - 05/2010
9	Infarction (Infarctions) 01/2018 - 05/2002
9	Stroke (Strokes) 11/2015 - 03/2009
8	Arthritis (Polyarthritis) 11/2017 - 01/2002
7	Glucose Intolerance 12/2013 - 04/2010
7	Dyspnea (Shortness of Breath) 09/2013 - 07/2005
6	Cardiomegaly (Heart Hypertrophy) 01/2018 - 08/2003
6	Diabetes Mellitus 07/2016 - 11/2003
6	Albuminuria 12/2013 - 12/2009
6	Essential Hypertension 12/2011 - 03/2002
5	Necrosis 03/2019 - 02/2007
5	Type 2 Diabetes Mellitus (MODY) 01/2018 - 12/2010
5	Hypotension (Low Blood Pressure) 01/2017 - 05/2008
5	Diabetic Nephropathies (Diabetic Nephropathy) 12/2013 - 09/2002
5	Liver Diseases (Liver Disease) 07/2011 - 11/2007
4	Rheumatoid Arthritis 11/2017 - 11/2006
4	Osteoarthritis 11/2017 - 11/2006
4	Coronary Artery Disease (Coronary Atherosclerosis) 11/2017 - 02/2007
4	Cardiac Sudden Death (Sudden Cardiac Arrest) 07/2017 - 08/2005
4	Obesity 05/2017 - 12/2011
4	Disease Progression 01/2017 - 01/2003
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2014 - 01/2003
4	Diabetic Cardiomyopathies 05/2012 - 11/2007
4	Insulin Resistance 01/2012 - 05/2011
4	Myocardial Ischemia (Ischemic Heart Diseases) 10/2011 - 11/2005
4	Portal Hypertension 07/2011 - 11/2007

Drug/Important Bio-Agent (IBA)

25	Eplerenone (Inspra)FDA LinkGeneric 01/2017 - 10/2002
24	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019 - 02/2004
21	CollagenIBA 10/2021 - 08/2003
20	Mineralocorticoid Receptor AntagonistsIBA 01/2017 - 10/2002
19	Pharmaceutical PreparationsIBA 01/2017 - 01/2002
18	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022 - 08/2002
15	urotensin IIIBA 10/2012 - 01/2003
14	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 05/2002
13	AldosteroneIBA 11/2014 - 10/2002
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
12	Carvedilol (Coreg)FDA LinkGeneric 08/2017 - 10/2002
12	Glucose (Dextrose)FDA LinkGeneric 05/2015 - 04/2010
11	Valsartan (Vals)FDA Link 01/2015 - 09/2002
10	Antihypertensive Agents (Antihypertensives)IBA 01/2018 - 10/2002
9	salicylhydroxamic acid (SHAM)IBA 01/2018 - 08/2003
9	DiureticsIBA 01/2017 - 06/2006
9	Peptides (Polypeptides)IBA 10/2012 - 08/2003
8	pro-brain natriuretic peptide (1-76)IBA 01/2019 - 02/2004
8	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2018 - 08/2002
7	Natriuretic PeptidesIBA 01/2018 - 02/2004
7	Neprilysin (Neutral Endopeptidase)IBA 01/2018 - 08/2002
7	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 11/2017 - 03/2005
7	Celecoxib (Celebrex)FDA Link 11/2017 - 01/2002
7	Endothelins (Endothelin)IBA 01/2017 - 03/2002
7	Enalapril FDA LinkGeneric 04/2016 - 08/2002
7	Angiotensin Receptor AntagonistsIBA 12/2015 - 05/2004
7	ReninIBA 05/2013 - 01/2003
7	Bisoprolol (Concor)FDA LinkGeneric 04/2011 - 11/2003
6	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2018 - 09/2002
6	Endothelin Receptors (Endothelin Receptor)IBA 01/2017 - 03/2002
6	Endothelin Receptor AntagonistsIBA 01/2017 - 03/2003
6	Messenger RNA (mRNA)IBA 10/2016 - 11/2005
6	CytokinesIBA 02/2016 - 02/2007
6	AngiotensinsIBA 04/2015 - 01/2005
6	Spironolactone (Aldactone)FDA LinkGeneric 08/2013 - 10/2002
6	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 12/2012 - 01/2002
5	Biomarkers (Surrogate Marker)IBA 05/2017 - 06/2010
5	IndicanIBA 01/2017 - 07/2010
5	Uremic ToxinsIBA 01/2017 - 11/2012
5	aliskiren FDA Link 04/2016 - 09/2010
5	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016 - 01/2002
5	tranilastIBA 12/2013 - 02/2005
5	Nateglinide (Starlix)FDA LinkGeneric 12/2013 - 04/2010
5	Vasoconstrictor AgentsIBA 02/2013 - 07/2005
5	Diclofenac (SR 38)FDA LinkGeneric 12/2012 - 01/2002
4	PotassiumIBA 01/2022 - 06/2012
4	Digoxin (Digitek)FDA LinkGeneric 01/2022 - 07/2006
4	MAP Kinase Kinase Kinase 5IBA 01/2021 - 01/2017
4	Atrial Natriuretic Factor (ANF)IBA 01/2018 - 01/2012
4	Naproxen (Naprosyn)FDA LinkGeneric 11/2017 - 01/2002
4	Leucine (L-Leucine)FDA Link 01/2017 - 09/2010
4	tezosentanIBA 01/2017 - 03/2003
4	finerenoneIBA 07/2016 - 06/2012
4	Renin InhibitorsIBA 04/2016 - 09/2010
4	EtoricoxibIBA 12/2012 - 11/2006
4	rofecoxib (Vioxx)FDA Link 09/2010 - 01/2002

Therapy/Procedure

100	Therapeutics 01/2022 - 01/2002
27	Denervation 09/2017 - 04/2009
12	Sympathectomy (Sympathectomies) 02/2015 - 04/2009
11	Catheters 07/2014 - 04/2009
9	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
7	Cardiac Resynchronization Therapy 01/2018 - 05/2010
5	Polypharmacy 07/2016 - 07/2005
4	Radiofrequency Ablation 02/2014 - 12/2011